Construction of Bifidobacterium infantis as a live oral vaccine that expresses antigens of the major fimbrial subunit (CfaB) and the B subunit of heat-labile enterotoxin (LTB) from enterotoxigenic Escherichia coli

Microbiology

Volumn 158, Issue 2, 2012, Pages 498-504

  Ma, Yongping ^a   Luo, Yaolin ^a   Huang, Xueping ^a   Song, Fangzhou ^a   Liu, Geli ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL VECTOR; ESCHERICHIA COLI ENTEROTOXIN; ESCHERICHIA COLI PROTEIN; ESCHERICHIA COLI VACCINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; PROTEIN CFAB; PROTEIN LTB; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIUM LONGUM INFANTIS; CONTROLLED STUDY; ELECTROPHORESIS; ENTEROTOXIGENIC ESCHERICHIA COLI; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI INFECTION; IMMUNIZATION; IMMUNOGENICITY; IN VIVO STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; BACTERIAL TOXINS; BACTERIAL VACCINES; BIFIDOBACTERIUM; ENTEROTOXIGENIC ESCHERICHIA COLI; ENTEROTOXINS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FIMBRIAE PROTEINS; GENE EXPRESSION; GENETIC VECTORS; HUMANS; MALE; RATS; RATS, SPRAGUE-DAWLEY; VACCINES, ATTENUATED;

BIFIDOBACTERIUM LONGUM BV. INFANTIS; ESCHERICHIA COLI; RATTUS;

EID: 84863023173     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.049932-0     Document Type: Article

References (28)

1. Adachi, J. A., Jiang, Z., Cox, M., Wood, L., DuPont, H. L. & Mathewson, J. J. (2000). Serum antibody response induced in mice after oral administration of three different antigens of enterotoxigenic Escherichia coli in enteric coated microparticles. J Travel Med 7, 304-308
2. Barry, E. M., Altboum, Z., Losonsky, G. & Levine, M. M. (2003). Immune responses elicited against multiple enterotoxigenic Escherichia coli fimbriae and mutant LT expressed in attenuated Shigella vaccine strains. Vaccine 21, 333-340
3. Bermudez-Humaran, L. G. (2009). Lactococcus lactis as a live vector for mucosal delivery of therapeutic proteins. Hum Vaccin 5, 264-267
4. Bhaskaran, S., Jay, C. M., Berghman, L. R., Wagner, G. G. & Waghela, S. D. (2005). A single-chain fragment variable recombinant antibody against F5 fimbria of enterotoxigenic Escherichia coli inhibits agglutination of horse red blood cells induced by F5 protein. Vet Res Commun 29, 463-476
5. Boedeker, E. C. (2005). Vaccines for enterotoxigenic Escherichia coli: current status. Curr Opin Gastroenterol 21, 15-19
6. Bühler, T., Hoschützky, H. & Jann, K. (1991). Analysis of colonization factor antigen I, an adhesin of enterotoxigenic Escherichia coli O78: H11: fimbrial morphology and location of the receptor-binding site. Infect Immun 59, 3876-3882
7. Byrd, W. & Cassels, F. J. (2006). The encapsulation of enterotoxigenic Escherichia coli colonization factor CS3 in biodegradable microspheres enhances the murine antibody response following intranasal administration. Microbiology 152, 779-786
8. Daley, A., Randall, R., Darsley, M., Choudhry, N., Thomas, N., Sanderson, I. R., Croft, N. M. & Kelly, P. (2007). Genetically modified enterotoxigenic Escherichia coli vaccines induce mucosal immune responses without inflammation. Gut 56, 1550-1556
9. Dupont, H. L. (2008). Systematic review: prevention of travellers' diarrhoea. Aliment Pharmacol Ther 27, 741-751
10. Gaastra, W. & Svennerholm, A. M. (1996). Colonization factors of human enterotoxigenic Escherichia coli (ETEC). Trends Microbiol 4, 444-452
11. Girard, M. P., Steele, D., Chaignat, C. L. & Kieny, M. P. (2006). A review of vaccine research and development: human enteric infections. Vaccine 24, 2732-2750
12. Guarner, F. & Malagelada, J. R. (2003). Gut flora in health and disease. Lancet 361, 512-519
13. Hanniffy, S. B., Carter, A. T., Hitchin, E. & Wells, J. M. (2007). Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection. J Infect Dis 195, 185-193
14. Johnson, A. M., Kaushik, R. S., Francis, D. H., Fleckenstein, J. M. & Hardwidge, P. R. (2009). Heat-labile enterotoxin promotesEscherichia coli adherence to intestinal epithelial cells. J Bacteriol 191, 178-186
15. Lee, J. C., Park, J. S., Shepherd, S. E., Carey, V. & Fattom, A. (1997). Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats. Infect Immun 65, 4146-4151
16. Levine, M. M., Nalin, D. R., Hoover, D. L., Bergquist, E. J., Hornick, R. B. & Young, C. R. (1979). Immunity to enterotoxigenic Escherichia coli. Infect Immun 23, 729-736
17. Liu, J. K., Hou, X. L., Wei, C. H., Yu, L. Y., He, X. J., Wang, G. H., Lee, J. S. & Kim, C. J. (2009). Induction of immune responses in mice after oral immunization with recombinant Lactobacillus casei strains expressing enterotoxigenic Escherichia coli F41 fimbrial protein. Appl Environ Microbiol 75, 4491-4497
18. López-Gigosos, R., García-Fortea, P., Reina-Doña, E. & Plaza-Martín, E. (2007). Effectiveness in prevention of travellers' diarrhoea by an oral cholera vaccine WC/rBS. Travel Med Infect Dis 5, 380-384
19. Lund, B. M., Baird-Parker, T. C. & Gould, G. W. (2000). Microbiological Safety and Quality of Food, vol. 2. Gaithersburg, MD: Aspen Publishers.
20. Medina, M., Vintiñi, E., Villena, J., Raya, R. & Alvarez, S. (2010). Lactococcus lactis as an adjuvant and delivery vehicle of antigens against pneumococcal respiratory infections. Bioeng Bugs 1, 313-325
21. O'Sullivan, D. J. & Klaenhammer, T. R. (1993). Rapid mini-prep isolation of high-quality plasmid DNA from lactococcus and Lactobacillus spp. Appl Environ Microbiol 59, 2730-2733
22. Pascual, D. W., Hone, D. M., Hall, S., van Ginkel, F. W., Yamamoto, M., Walters, N., Fujihashi, K., Powell, R. J., Wu, S. & other authors (1999). Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response. Infect Immun 67, 6249-6256
23. Pizza, M., Giuliani, M. M., Fontana, M. R., Monaci, E., Douce, G., Dougan, G., Mills, K. H., Rappuoli, R. & Del Giudice, G. (2001). Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants. Vaccine 19, 2534-2541
24. Sack, R. B. (1975). Human diarrheal disease caused by enterotoxigenic Escherichia coli. Annu Rev Microbiol 29, 333-353
25. Steinsland, H., Valentiner-Branth, P., Perch, M., Dias, F., Fischer, T. K., Aaby, P., Mølbak, K. & Sommerfelt, H. (2002). Enterotoxigenic Escherichia coli infections and diarrhea in a cohort of young children in Guinea-Bissau. J Infect Dis 186, 1740-1747
26. Uesaka, Y., Otsuka, Y., Lin, Z., Yamasaki, S., Yamaoka, J., Kurazono, H. & Takeda, Y. (1994). Simple method of purification of Escherichia coli heat-labile enterotoxin and cholera toxin using immobilized galactose. Microb Pathog 16, 71-76
27. Wang, L., Huang, J. A., Nagesha, H. S., Smith, S. C., Phelps, A., Holmes, I., Martyn, J. C., Coloe, P. J. & Reeves, P. R. (1999). Bacterial expression of the major antigenic regions of porcine rotavirus VP7 induces a neutralizing immune response in mice. Vaccine 17, 2636-2645
28. Wei, C. H., Liu, J. K., Hou, X. L., Yu, L. Y., Lee, J. S. & Kim, C. J. (2010). Immunogenicity and protective efficacy of orally or intranasally administered recombinant Lactobacillus casei expressing ETEC K99. Vaccine 28, 4113-4118.